Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-05-2024 | Sarilumab | Case report

Alendronic-acid/sarilumab

Medication-related osteonecrosis of the jaw, necrotising fasciitis and Bacteroides pyogenes infection

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Ishibashi H, et al. Necrotizing Fasciitis with Medication-related Osteonecrosis of the Jaw. Internal Medicine 63: 887-888, No. 6, Jan 2024. Available from: URL: https://dx.doi.org/10.2169/internalmedicine.2442-23 Ishibashi H, et al. Necrotizing Fasciitis with Medication-related Osteonecrosis of the Jaw. Internal Medicine 63: 887-888, No. 6, Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​2169/​internalmedicine​.​2442-23
Metadata
Title
Alendronic-acid/sarilumab
Medication-related osteonecrosis of the jaw, necrotising fasciitis and Bacteroides pyogenes infection
Publication date
01-05-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57923-y

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Ezetimibe/Niacin

Case report

Polidocanol